SUBSCRIBE
SUBSCRIBE
News   FDA

Cadila Pharmaceuticals’s Drug for Rheumatoid Arthritis Gets U.S. Okay

September 25, 2007 | 
1 min read

MUMBAI (Reuters) - Cadila Healthcare Ltd said on Tuesday it received approval from U.S. health regulators for its hydroxychloroquine sulphate tablets.

FDA Approvals Asia
MORE ON THIS TOPIC
Close-Up Of Medicine Bottles Against Green Background
Opinion
FDA Faces Challenging Decision on Biomarker-Based Label Restrictions
March 10, 2025
 · 
5 min read
 · 
Harpreet Singh
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: GSK, Alnylam, Sanofi and More
March 10, 2025
 · 
7 min read
 · 
Tristan Manalac
Editorial
FDA Weathers Bait-and-Switch Storm as Staff and Sites Come and Go
March 7, 2025
 · 
3 min read
 · 
Jef Akst
Composite photo collage of hand hold magnifier glass research examine secret object question mark secret isolated on painted background.
Editorial
This Might Be a Moot Point but the FDA’s Priority Review Vouchers Need Transparency
March 7, 2025
 · 
3 min read
 · 
Annalee Armstrong